2015 annual financial data
Spero Therapeutics 2015 Net margin
Spero Therapeutics 2015 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -13,327,000 USD and net income was -10,154,000 USD.
Operating cash flow was -9,608,000 USD.
Get free Spero Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,327,000 USD
- Net income
- -10,154,000 USD
- Operating cash flow
- -9,608,000 USD